Biomaterial Database

[Guidelines for clinical use of drugs for involutional osteoporosis]. 1998

I Yamamoto

Shiga University of Medical Science.

Guidelines for clinical use of drugs for involutional osteoporosis will be released soon in Japan. Seven different types of drugs for osteoporosis are in market for clinical use in Japan. Those includes calcium, estrogens, anabolic steroids, calcitonins, active vitamin D3, ipriflavon, and etidronate. The guidelines recommend to clarify the risk factors in each patient before to start administration of drug. Patients with osteopenia are basically recommended to be followed without any drug treatment, but, patients with osteoporosis are generally recommended to be treated with drug after evaluation of risk factors. After menopause, inhibitors of bone resorption would be recommended as a first choice drug. For monitoring effects of treatment, bone mass measurement is so far the first choice, but bone metabolic markers would be used as well.

UI	MeSH Term	Description	Entries
D010024	Osteoporosis	Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.	Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017410	Practice Guidelines as Topic	Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.	Clinical Guidelines as Topic,Best Practices,Best Practice